Stay updated on Relatlimab + Nivolumab Bioavailability Clinical Trial

Sign up to get notified when there's something new on the Relatlimab + Nivolumab Bioavailability Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relatlimab + Nivolumab Bioavailability Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision: v3.5.4 is now displayed, replacing the previous v3.5.3. This indicates a newer version of the page has been published.
    Difference
    0.1%
    Check dated 2026-05-14T23:08:52.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page updates its revision history to v3.5.3, replacing the previous v3.5.2. This represents a routine metadata update to the study record rather than a substantive change to the study details.
    Difference
    0.1%
    Check dated 2026-04-30T16:53:34.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    - Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:51:39.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-18T17:56:20.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This is a minor technical update to the page revision.
    Difference
    0.1%
    Check dated 2026-03-11T15:33:05.000Z thumbnail image
  9. Check
    114 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2. The prior funding-lapse notice (v3.4.1) has been removed.
    Difference
    0.5%
    Check dated 2026-02-11T02:14:23.000Z thumbnail image

Stay in the know with updates to Relatlimab + Nivolumab Bioavailability Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relatlimab + Nivolumab Bioavailability Clinical Trial page.